Hervé Ghesquières Selected Research

Residual Neoplasm

1/2023	Impact on Outcome of Minimal Residual Disease after Hematopoietic Stem Cell Transplantation with Fludarabine, Amsacrine, and Cytosine Arabinoside-Busulfan Conditioning: A Retrospective Monocentric Study.
1/2021	The Impact of DNMT3A Status on NPM1 MRD Predictive Value and Survival in Elderly AML Patients Treated Intensively.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hervé Ghesquières Research Topics

Disease

24	Lymphoma (Lymphomas) 02/2024 - 03/2009
14	Hodgkin Disease (Hodgkin's Disease) 03/2024 - 11/2013
11	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2022 - 09/2008
10	Neoplasms (Cancer) 01/2023 - 09/2006
9	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2022 - 01/2010
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 04/2011
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020 - 09/2015
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2021
2	Residual Neoplasm 01/2023 - 01/2021
2	Infections 12/2022 - 01/2021
2	Disease Progression 10/2022 - 01/2019
2	Multiple Myeloma 01/2020 - 10/2008
2	Pathologic Complete Response 01/2017 - 12/2014
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 02/2024
1	Cytopenia 10/2023
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 07/2023
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2023
1	Extranodal NK-T-Cell Lymphoma 01/2023
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2022
1	Sclerosis 10/2022
1	Herpes Zoster 01/2022
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020
1	Inflammation (Inflammations) 10/2019
1	Autoimmune Diseases (Autoimmune Disease) 10/2019
1	Uveitis 04/2018
1	Lymphadenopathy 10/2017
1	Necrosis 01/2017

Drug/Important Bio-Agent (IBA)

15	Rituximab (Mabthera)FDA Link 02/2024 - 09/2008
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2023 - 09/2008
5	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2024 - 09/2008
5	Vincristine (Oncovin)FDA LinkGeneric 12/2022 - 09/2008
4	Prednisone (Sone)FDA LinkGeneric 03/2024 - 09/2008
4	Bendamustine Hydrochloride FDA Link 03/2024 - 11/2013
4	Brentuximab VedotinIBA 07/2023 - 06/2018
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 12/2014
4	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 11/2012
4	Etoposide (VP 16)FDA LinkGeneric 12/2022 - 04/2011
4	CytokinesIBA 10/2022 - 01/2010
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2021 - 06/2019
4	Melphalan (Alkeran)FDA LinkGeneric 01/2021 - 10/2008
4	Monoclonal AntibodiesIBA 01/2020 - 11/2011
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 10/2014
3	NivolumabIBA 01/2020 - 01/2017
2	AntibodiesIBA 10/2023 - 01/2023
2	Busulfan (Busulfex)FDA Link 01/2023 - 11/2012
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 10/2008
2	Chimeric Antigen ReceptorsIBA 08/2021 - 11/2020
2	Interleukin-10 (Interleukin 10)IBA 04/2018 - 01/2010
2	Interleukin-6 (Interleukin 6)IBA 04/2018 - 01/2010
2	Yttrium-90IBA 12/2014 - 04/2011
2	ibritumomab tiuxetan (Zevalin)FDA Link 12/2014 - 04/2011
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2013 - 09/2007
1	Vinblastine (Vinblastine Sulfate)FDA Link 03/2024
1	Chlorambucil (Leukeran)FDA Link 02/2024
1	Immunoglobulins (Immunoglobulin)IBA 10/2023
1	Prednisolone (Predate)FDA LinkGeneric 07/2023
1	fludarabineIBA 01/2023
1	ibrutinibIBA 01/2023
1	Gemcitabine FDA Link 01/2023
1	Amsacrine (AMSA)IBA 01/2023
1	Asparaginase (Elspar)FDA Link 01/2023
1	HLA-DR Antigens (HLA-DR)IBA 01/2023
1	Ifosfamide FDA LinkGeneric 12/2022
1	Carboplatin (JM8)FDA LinkGeneric 12/2022
1	IceIBA 12/2022
1	Cyclin D1IBA 11/2022
1	Galectin 1 (LGALS1)IBA 10/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	IgKIBA 01/2022
1	B7-H1 AntigenIBA 01/2021
1	Biological FactorsIBA 01/2021
1	tafasitamabIBA 01/2021
1	obinutuzumabIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	axicabtagene ciloleucelIBA 11/2020
1	tisagenlecleucelIBA 11/2020
1	LipidsIBA 01/2020
1	FluorineIBA 01/2020
1	Immunomodulating AgentsIBA 01/2020
1	pembrolizumabIBA 01/2020
1	AntigensIBA 10/2019
1	InterleukinsIBA 04/2018
1	AnthracyclinesIBA 12/2017
1	Hemoglobins (Hemoglobin)IBA 10/2017
1	Procarbazine (Matulane)FDA Link 06/2017

Therapy/Procedure

19	Drug Therapy (Chemotherapy) 06/2023 - 09/2008
14	Therapeutics 03/2024 - 12/2014
10	Stem Cell Transplantation 01/2022 - 10/2008
5	Radiotherapy 06/2023 - 03/2009
5	Hematopoietic Stem Cell Transplantation 01/2023 - 01/2019
3	Transplantation 12/2020 - 10/2008
2	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 09/2012
2	BEAM regimen 12/2014 - 04/2011
1	Chemoradiotherapy 01/2023
1	Salvage Therapy 12/2022
1	Immunomodulation 01/2020
1	Cell Transplantation 01/2017
1	Homologous Transplantation 01/2017